Functional neovascularization of biodegradable dextran hydrogels with multiple angiogenic growth factors

Biomaterials

Volumn 32, Issue 1, 2011, Pages 95-106

  Sun, Guoming ^a   Shen, Yu I ^a   Kusuma, Sravanti ^a,b   Fox Talbot, Karen ^c   Steenbergen, Charles J ^c   Gerecht, Sharon ^a  

^a Johns Hopkins University   (United States)

^b Johns Hopkins University   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Dextran; Growth factor; Scaffold; Wound healing

Indexed keywords

ANGIOGENESIS; ANGIOGENIC GROWTH FACTORS; ANGIOPOIETINS; BIODEGRADABLE HYDROGELS; COIMMOBILIZATION; CROSS-LINKING DENSITY; DEGREE OF SUBSTITUTION; GROWTH FACTOR; HYDROGEL SCAFFOLDS; HYDROGEL STRUCTURE; NEOVASCULARIZATION; STROMAL CELLS; SYNERGISTIC EFFECT; THERAPEUTIC APPLICATION; TISSUE CONSTRUCTS; TISSUE IN-GROWTH; VASCULARIZATION; VASCULATURE; WOUND HEALING;

BIODEGRADATION; BLOOD; BLOOD VESSELS; CROSSLINKING; DEXTRAN; GLUCOSE; PEPTIDES; SCAFFOLDS; TISSUE;

HYDROGELS;

ACRYLIC ACID DERIVATIVE; ANGIOPOIETIN 1; DEXTRAN; GROWTH FACTOR; ISOCYANIC ACID DERIVATIVE; MACROGOL; POLYMER; SOMATOMEDIN; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN; VASCULOTROPIN 165;

ANGIOGENESIS; ARTICLE; BIODEGRADATION; BLOOD VESSEL; CROSS LINKING; HYDROGEL; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; SYNTHESIS; WOUND HEALING;

ALLYL COMPOUNDS; ANGIOGENESIS INDUCING AGENTS; ANIMALS; BIOCOMPATIBLE MATERIALS; BLOOD VESSELS; DEXTRANS; DRUG DELIVERY SYSTEMS; HUMANS; HYDROGELS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOCYANATES; MECHANICAL PHENOMENA; NEOVASCULARIZATION, PHYSIOLOGIC; POLYETHYLENE GLYCOLS; PROSTHESIS IMPLANTATION; RATS; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78349308470     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.08.091     Document Type: Article

References (41)

1. Kraehenbuehl T.P., Ferreira L.S., Zammaretti P., Hubbell J.A., Langer R. Cell-responsive hydrogel for encapsulation of vascular cells. Biomaterials 2009, 30(26):4318-4324.
2. Srivastava D., Ivey K.N. Potential of stem-cell-based therapies for heart disease. Nature 2006, 441(7097):1097-1099.
3. Adams B., Xiao Q., Xu Q. Stem cell therapy for vascular disease. Trends Cardiovasc Med 2007, 17(7):246-251.
4. Sales K.M., Salacinski H.J., Alobaid N., Mikhail M., Balakrishnan V., Seifalian A.M. Advancing vascular tissue engineering: the role of stem cell technology. Trends Biotechnol 2005, 23(9):461-467.
5. Sun G.M., Gerecht S. Vascular regeneration: engineering the stem cell microenvironment. Regenerative Med 2009, 4(3):435-447.
6. Yang S.F., Leong K.F., Du Z.H., Chua C.K. The design of scaffolds for use in tissue engineering. Part 1. Traditional factors. Tissue Eng 2001, 7(6):679-689.
7. Ravi S., Chaikof E.L. Biomaterials for vascular tissue engineering. Regenerative Med 2010, 5(1):107-120.
8. Guiducci S., Distler O., Distler J.H.W., Matucci-Cerinic M. Mechanisms of vascular damage in SSc-implications for vascular treatment strategies. Rheumatology (Oxford) 2008, 47(Suppl.5):v18-20.
9. Hanjaya-Putra D., Gerecht S. Vascular engineering using human embryonic stem cells. Biotechnol Prog 2009, 25(1):2-9.
10. Banfi A., von Degenfeld G., Blau H. Critical role of microenvironmental factors in angiogenesis. Curr Atheroscler Rep 2005, 7(3):227-234.
11. Richardson T.P., Peters M.C., Ennett A.B., Mooney D.J. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001, 19(11):1029-1034.
12. Fan X., Krieg S., Kuo C.J., Wiegand S.J., Rabinovitch M., Druzin M.L., et al. VEGF blockade inhibits angiogenesis and reepithelialization of endometrium. FASEB J 2008, 22(10):3571-3580.
13. Peattie R.A., Nayate A.P., Firpo M.A., Shelby J., Fisher R.J., Prestwich G.D. Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants. Biomaterials 2004, 25(14):2789-2798.
14. Prior B.M., Yang H.T., Terjung R.L. What makes vessels grow with exercise training?. J Appl Phys 2004, 97(3):1119-1128.
15. Fleissner F., Thum T. The IGF-1 receptor as a therapeutic target to improve endothelial progenitor cell function. Mol Med 2008, 14(5-6):235-237.
16. Delafontaine P., Song Y.H., Li Y.X. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler Thromb Vasc Biol 2004, 24(3):435-444.
17. Petit I., Jin D., Rafii S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 2007, 28(7):299-307.
18. Urbich C., Dimmeler S. Endothelial progenitor cells - characterization and role in vascular biology. Circ Res 2004, 95(4):343-353.
19. Chen J.-X., Stinnett A. Disruption of Ang-1/Tie-2 signaling contributes to the impaired myocardial vascular maturation and angiogenesis in type II diabetic mice. Arterioscler Thromb Vasc Biol 2008, 28(9):1606-1613.
20. Phelps E.A., Landázuri N., Thulé P.M., Taylor W.R., García A.J. Bioartificial matrices for therapeutic vascularization. Proc Natl Acad Sci U S A 2010, 107(8):3323-3328.
21. Sheridan M.H., Shea L.D., Peters M.C., Mooney D.J. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Release 2000, 64(1-3):91-102.
22. Perets A., Baruch Y., Weisbuch F., Shoshany G., Neufeld G., Cohen S. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res Part A 2003, 65A(4):489-497.
23. Riley C.M., Fuegy P.W., Firpo M.A., Zheng Shu X., Prestwich G.D., Peattie R.A. Stimulation of in vivo angiogenesis using dual growth factor-loaded crosslinked glycosaminoglycan hydrogels. Biomaterials 2006, 27(35):5935-5943.
24. Elia R., Fuegy P.W., VanDelden A., Firpo M.A., Prestwich G.D., Peattie R.A. Stimulation of in vivo angiogenesis by in situ crosslinked, dual growth factor-loaded, glycosaminoglycan hydrogels. Biomaterials 2010, 31(17):4630-4638.
25. Hosack L.W., Firpo M.A., Scott J.A., Prestwich G.D., Peattie R.A. Microvascular maturity elicited in tissue treated with cytokine-loaded hyaluronan-based hydrogels. Biomaterials 2008, 29(15):2336-2347.
26. Pike D.B., Cai S., Pomraning K.R., Firpo M.A., Fisher R.J., Shu X.Z., et al. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials 2006, 27(30):5242-5251.
27. Lee K.Y., Peters M.C., Anderson K.W., Mooney D.J. Controlled growth factor release from synthetic extracellular matrices. Nature 2000, 408(6815):998-1000.
28. Dvir T., Kedem A., Ruvinov E., Levy O., Freeman I., Landa N., et al. Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc Natl Acad Sci U S A 2009, 106(35):14990-14995.
29. Bos G.W., Hennink W.E., Brouwer L.A., den Otter W., Veldhuis T.F.J., van Nostrum C.F., et al. Tissue reactions of in situ formed dextran hydrogels crosslinked by stereocomplex formation after subcutaneous implantation in rats. Biomaterials 2005, 26(18):3901-3909.
30. Ferreira L.S., Gerecht S., Fuller J., Shieh H.F., Vunjak-Novakovic G., Langer R. Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. Biomaterials 2007, 28(17):2706-2717.
31. Sun G., Shen Y.-I., Ho C.C., Kusuma S., Gerecht S. Functional groups affect physical and biological properties of dextran-based hydrogels. J Biomed Mater Res Part A 2010, 93A(3):1080-1090.
32. Sun G.M., Chen F.A., Chu C.C. Effects of precursor and cross-linking parameters on the properties of dextran-allyl isocyanate-ethylamine/poly(ethylene glycol diacrylate) biodegradable hydrogels and their release of ovalbumin. J Biomater Sci-Polym Ed 2009, 20(14):2003-2022.
33. Sun G., Chu C.-C. Synthesis, characterization of biodegradable dextran-allyl isocyanate-ethylamine/polyethylene glycol-diacrylate hydrogels and their in vitro release of albumin. Carbohydr Polym 2006, 65(3):273-287.
34. Gong J.P., Katsuyama Y., Kurokawa T., Osada Y. Double-network hydrogels with extremely high mechanical strength. Adv Mater 2003, 15(14):1155-1158.
35. Rafii S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003, 9(6):702-712.
36. Murphy W.L., Peters M.C., Kohn D.H., Mooney D.J. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 2000, 21(24):2521-2527.
37. Mikos A.G., Sarakinos G., Lyman M.D., Ingber D.E., Vacanti J.P., Langer R. Prevascularization of porous biodegradable polymers. Biotechnol Bioeng 1993, 42(6):716-723.
38. Langer R. New methods of drug delivery. Science 1990, 249(4976):1527-1533.
39. Cao Y., Mitchell G., Messina A., Price L., Thompson E., Penington A., et al. The influence of architecture on degradation and tissue ingrowth into three-dimensional poly(lactic-co-glycolic acid) scaffolds in vitro and in vivo. Biomaterials 2006, 27(14):2854-2864.
40. Asahara T., Bauters C., Zheng L.P., Takeshita S., Bunting S., Ferrara N., et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 1995, 92(9):365-371.
41. Keskar V., Gandhi M., Gemeinhart E.J., Gemeinhart R.A. Initial evaluation of vascular ingrowth into superporous hydrogels. J Tissue Eng Regen Med 2009, 3(6):486-490.